BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 17639093)

  • 21. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
    Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
    Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
    Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
    Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
    Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
    EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very long-term follow-up after percutaneous closure of patent foramen ovale.
    Eeckhout E; Martin S; Delabays A; Michel P; Girod G
    EuroIntervention; 2015 Apr; 10(12):1474-9. PubMed ID: 24429213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience.
    Węglarz P; Konarska Kuszewska E; Spisak Borowska K; Machowski J; Drzewiecka-Gerber A; Kuszewski P; Jackson CL; Opala G; Trusz Gluza M
    Kardiol Pol; 2012; 70(5):478-84. PubMed ID: 22623240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
    Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
    Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience.
    Mangieri A; Godino C; Montorfano M; Arioli F; Rosa I; Ajello S; Piraino D; Monello A; Pavon AG; Viani G; Magni V; Cappelletti A; Margonato A; Colombo A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):105-12. PubMed ID: 25382155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale.
    Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
    Int J Cardiol; 2007 Sep; 120(3):357-62. PubMed ID: 17166607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
    Rigatelli G; Giordan M; Braggion G; Aggio S; Chinaglia M; Zattoni L; Milan T; Cardaioli P
    Cardiovasc Revasc Med; 2007; 8(4):248-50. PubMed ID: 18053946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
    Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
    Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.